The Scientific Platform Pasteur-USP (SPPU) carries out studies especially focused on emerging and
neglected infectious diseases that are transmitted by pathogens that cause complex immune responses, produce nervous
system disorders, and impact human and animal public health.
The SPPU works as an Emergency Cell and its main
objective is to curb epidemics of those diseases by developing preventive, diagnostic/prognostic, and therapeutic
Located in the Inova USP Research and Innovation Center, in São Paulo, in a 1,700 m² area, the Platform
consists of 17 laboratories, four of which are biosecurity level 3 (NB3) – comparable to the European
The researchers involved with the SPPU share their areas of expertise, infrastructure, and cutting-edge
equipment. This approach purposes to strengthen the development of joint initiatives with a view to discovering new
products and processes, as well as to transferring and applying those innovations.
The SPPU is the result of a
three-way agreement between the Pasteur Institute, the University of São Paulo (USP), and the Oswaldo Cruz Foundation
(Fiocruz). It is currently a part of the Pasteur Network.